How to harness the power of the organoids to increase/improve preclinical and translational insight? – Organoid applications in personalized medicine drug discovery
-Organoids for disease modeling –Brain organoids: opportunities and limitations for the study of neurodevelopmental abnormalities.
Co-chair: Amritha Jaishankar, PhD, Manager,
Maryland Stem Cell Research Fund (MSCRF)
Thomas Shupe, PhD
Scientific Coordinator XCEL Program, Wake Forest Institute for Regenerative Medicine
Colin Bishop, PhD
Wake Forest Institute for Regenerative Medicine (WFIRM)